Anna Campain's Publications

About Anna Campain's Publications

Senior Biostatistician
  • Conjoint Lecturer, Faculty of Medicine, UNSW Sydney
  • PhD, BSc (Adv Maths)

  • P5319Evidence-practice gaps in the screening and management of cardiovascular risk factors in the Australian General Practice population

    European Heart Journal Date published:

  • Cardiovascular disease (CVD) risk identification and management in Australian primary care. Why an implementation strategy is needed

    Date published:

  • No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort study

    Clinical & Experimental Ophthalmology Date published:

  • Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema

    Cochrane Database of Systematic Reviews Date published:

  • TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    Retina Date published:

  • Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)

    Ophthalmology Date published:

  • Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

    British Journal of Ophthalmology Date published:

  • Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

    British Journal of Ophthalmology Date published:

  • Long-Term Outcomes of Treatment of Neovascular Age-Related Macular Degeneration

    Ophthalmology Date published:

  • Patient experiences in retinal trials: a cross-sectional study

    BMC Ophthalmology Date published:

  • Two-Year Outcomes of “Treat and Extend” Intravitreal Therapy for Neovascular Age-Related Macular Degeneration

    Ophthalmology Date published:

  • Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema

    Cochrane Database of Systematic Reviews Date published:

  • Time to Initial Clinician-Reported Inactivation of Neovascular Age-Related Macular Degeneration Treated Primarily with Ranibizumab

    Ophthalmology Date published:

  • A Randomized Clinical Trial of Intravitreal Bevacizumab versus Intravitreal Dexamethasone for Diabetic Macular Edema

    Ophthalmology Date published:

  • Intravitreal Therapy in Bilateral Neovascular Age-Related Macular Degeneration

    Ophthalmology Date published:

  • Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data

    British Journal of Ophthalmology Date published: